chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dry cough, sore arm, fatigue, and nausea. On day 3, all side effects went away except for my dry cough which has been consistent ever since I got it right after the shot.
Headache Nausea  Vomiting  Nosebleed  Fever/chills Weakness Dizziness  Severe injection site soreness Stabbing/burning pain radiating down arm from the injection site  Severe joint pain  General exhaustion Loss of appetite Rash Symptoms are being treated with Tylenol. Symptoms have not yet abated. I am currently unable to complete activities of daily living such as showering or meal preparation due to the severity of symptoms, namely dizziness and weakness.
Two days post vax pt experienced fever of 104.6. Medical attention was sought. No further info is available.
Info has been received from a registered nurse concerning a 72 year old female (conflicting follow-up info indicated pt was male) with allergies to propoxyphene HCl (DARVON), naproxen (NAPROSYN), ibuprofen (MOTRIN) and hydromorphone HCl (DILAUDID) who on 06/06/2002 was vaccinated with a second dose of pneumococcal vaccine 23 polyvalent intramuscularly in the deltoid (lot 640577/0995L). Concomitant therapy included fosinopril sodium (MONOPRIL), hydrochlorothiazide (manufacturer unknown), estrogens, conjugated (PREMARIN), aspirin and vitamins (unspecified). It was reported that the pt received a 1st dose of pneumococcal vaccine 23 polyvalent in 1993 without reaction. On 06/07/2002, the pt presented to the office with a temperature and her left upper arm was red, swollen and tender with the site extremely warm to the touch. The entire outer upper arm from mid deltoid to elbow was affected. The pt was treated with cephalexin 500 mg TID and prednisone 60 mg x 3 days, 40 mg x 3 days, and 20 mg x 3 days. The pt recovered on 06/08/2002. The nurse reported that the pt's injection site erythema, swelling, pain, and inflammation were considered other medical events. No additional info is expected.
Narrative:  On 9/24/2021 88yo male patient was transferred to the agency from nursing home for evaluation after fall. He was here for the same couple days ago at which time he underwent CT of the head as well as right upper extremity imaging for humerus fracture. Due to dementia, patient has not been keep his arm in the sling. Tonight he fell again resulting in dishiscience of rt upper lid sutured from 2 days ago. There is no LOC. NH sent pt for possible suturing. Pt otherwise denies any discomfort incl pain. ROS: Unable to obtain 2/2 dementia Past Medical History: SCC - Squamous cell carcinoma in situ ofCLL - Chronic lymphocytic leukemia Central retinal vein occlusion (SCT 6847Atrial Flutter (SCT 5370000) Hypothyroidism (SCT 40930008) Insomnia (SCT 193462001) Benign Prostatic Hypertrophy With OutfloRetention of Urine (SCT 267064002) Malignant melanoma of skin of lower limbConstipation (SCT 14760008) Behavioural disturbance co-occurrent andDebility (SCT 13791008) Seen by palliative care medicine service agency notified pt died on 9/29/2021. No information regarding pt's death provided. This death is likely not related to the vaccinations due to comorbidities, age, and length of time from vaccine administration.
High blood pressure of 175/96; Headache left side of head behind ear towards the neck; Muscle pain; Dizziness and lightheaded; Upset stomach; Nausea; This is a spontaneous report from a contactable consumer(patient). A 52-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ZP6955), via an unspecified route of administration, administered in Arm Left on 18Mar2021 16:30(Age at vaccination: 52 years) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization at Pharmacy or Drug Store. The patient past medical history included Thyroid hypothyroidism, endometriosis, hypoglycemic, sciatic nerve. Allergies to medications, food, or other products included  Aspirin. Concomitant medication incudes Levothyroxine Sodium (LEVOXYL) taken for an unspecified indication, Acetaminophen taken for an unspecified indication and Cefixime (FLEXERIL [CEFIXIME]) taken for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within 4 weeks prior to covid-19 vaccination. On 20Mar2021, the patient experienced Headache left side of head behind ear towards the neck, muscle pain, high blood pressure of 175/96 (not a patient of high blood pressure, always normal blood pressure of 120/60), dizziness. Lightheaded, upset stomach and nausea. The events resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The patient underwent lab tests which included blood pressure measurement: 120/60 on an unknown date, blood pressure measurement: 175/96 on 20Mar2021. Therapeutic measures were taken and treatment included The patient is treated with Pepcid, acetaminophen and flexeril. The event outcome was Not recovered.
Client received the first dose Moderna Covid 19 vaccine. Client received 2nd dose Pfizer Covid 19 vaccine. Client did not have any adverse effects or reactions.
sore arm; shakes; body aches; fever; chills; headaches; This is a spontaneous report from a contactable consumer (patient).   A 38-year-old female patient of an unspecified age received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration on 04Mar2021 (Batch/Lot number was not reported) as 1ST DOSE, SINGLE for covid-19 immunisation.  The patient's medical history and concomitant medications were not reported.  The patient received the first dose on Thursday (as reported) experienced sore arm but then developed shakes, body aches fever chills and headaches. These symptoms were worst on Monday (as reported). The patient is asking how long do symptoms usually last. The outcome of the events was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot been obtained. No further information is expected.
A 9 month old female came to a Dept of Health outreach clinic for her vaccinations. The ACTHIB was accidentally reconstituted with MENACTRA instead of the provided diluent and given to the child in her left thigh. The error was not caught until after the patient left the clinic. Once the error was discovered, Sanofi Pasteur was called and it was stated that there was no danger to the child. The mother of the patient was then notified of the error, that there was no danger to the child, and that the dose of HIB was invalid and would be re-administered next month.
Patient fainted for a few seconds. His mom and a technician helped him to a seat in our waiting room. He was then talking to us saying he felt fine. We were already calling 911 and they were on their way. I ran for EPIPEN but he said he felt fine. It wasn't an allergic reaction. The EMT did not use a EPIPEN either. I gave an MENACTRA injection to patient. The technician who entered the vaccination into the computer she did not go through the questions with him and mom using the immunization tool. When I went in the room with him I went over the vacs with him and everything was ok. I asked again if he ever had a severe reaction with a vaccine before. His mom said no. I then administered the shot and asked if he was okay as I do with all vaccinations. He said he was fine. I then gave the vac to a technician to make a copy of and for school. At that time I heard yelling as he fell over into his mom's arms. His mom sat him on a chair in our waiting room. I yelled to call 911 and ran for the EPIPEN. When I came out he was talking to us and said he was fine. I did not use the EPIPEN due to him saying he had no problem breathing and just felt sick. I went for the blood pressure machine and gave him a ice pack because he was sweating. The ambulance arrived and his blood pressure was fine. We advised him to get checked out due to a heart rate of 50. He is a football player and when I asked him he ate at all today he said "no". He kept saying he was fine as EMT's spoke with him. They decided to take him to the ER to get checked. The mom then called me and said he was doing fine and the doctor in the ER did not feel this was due to the vaccination. They felt it was syncope.
Patient reported feeling feverish and very tired.  She has been achy all over her body all day.  She feels very hot and likes she's been dragging all day.  She did admit to not eating very much at all.  She may try and take some tylenol and eat some food for nourishment.
Fever began in the evening: patient took acetaminophen; Body aches and pain, stomach upset, headache; Heaviness of eyes- feeling of them being closed. Patient called pharmacy in the afternoon - recommended patient to seek medical attention.
spoke to customer on 12/10/21 @4:30pm. Pt said she was fine now. But she experienced side effects.  She complaint pain, fever, chill, body ache, headache and  light shortness of breath for a short time.  Overall everything is fine now. All those symptoms resolved.
LARGE BLACK STOOLS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609 expiry: UNKNOWN) dose was not reported, administered on 01-APR-2021 to left deltoid for prophylactic vaccination. No concomitant medications were reported. On 02-APR-2021, the subject experienced large black stools. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from large black stools. This report was non-serious.
This spontaneous report as received from a pharmacist refers to a 19 month old patient of unknown gender. On 13-OCT-2014 the patient was inadvertently vaccinated with the second dose of VAQTA (route and lot number not reported) 1 ml, adult dose. The patient was due to receive dose 2 of pediatric VAQTA on 13-OCT-2014. No symptoms were reported. Additional information has been requested.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed the ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 11-MAR-2011, a healthcare provider at a clinic administered the ZOSTAVAX to the patient. On an unknown date in 2012, the patient was treated by a nurse practitioner for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of her injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not  limited to medical losses and costs including care for hospitalization (dates unknown), physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Client's mother reported that after leaving health dept on 3/22, her son c/o slight dizziness. She noticed that later (around 6:30) he seemed "groggy" and distracted and complained of itching around his abdominal area.  It was then that she noticed he had a "band of red swollen areas resembling mosquito bites" around his mid abdominal area extending to his back. At that time she called her provider and that recommended that she give him Benadryl which she gave him around 8 pm that night. At that time, she noticed that the areas were completely covering his abd and back area.  She gave him Benadryl X2 during the night and the she started him on Zyrtec yesterday afternoon as recommended by her MD. Followed up with client's mother on 3/24 at 2:45 PM and she reported that her son was feeling well...the rash was present but no itching or other symptoms.
Lump on collarbone or neck; This is a spontaneous report from a non-contactable consumer, the patient. A 50-year-old, non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in left arm on 01Apr2021 at 14:00 (at an age of 50-year-old) as single dose for COVID-19 immunisation. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route in left arm on 14Mar2021 at 16:00 hours as single dose for COVID-19 immunisation. The patient had known allergy to Morphine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19.Post the vaccination, the patient was not tested for COVID-19. On 02Apr2021 the patient had lump on collarbone/neck. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome for the event of lump on collarbone or neck was not resolved at the time of this report.   No follow-up attempts are possible; information about lot number cannot be obtained.
The pharmacist administered the right vaccine but the vaccine was past expiration date (expiration date: 07/15/2023)
8 days post-vaccine I woke up with shortness of breath and mind racing that turned into heart attack-like symptoms (shooting pain down left arm, couldn?t breathe, fear of death, lightheaded) and to call ambulance. Cardiologist said that I had inflammation around my heart. Since the medical event I have had four others. Notably, I have never had a history of these types of attacks and they started happening 8 days after first vaccine shot. I am 30 years old, 5?10?, 170 pounds. The vaccine has to have been the cause of these as lifestyle hasn?t changed one bit since vaccination.
A few days after vaccination patient had an unusual dry cough/ and then a pain in his chest, He called our Doctor she said call your cardiologist now, patient called Dr and told him he wanted to go to his office, explained the pain he was experiencing - the doctor told him  said he couldn't see him wanted to do a  telemed exam. and proceeded to tell patient to see an gastro entomologist, take Tums, no tomatoes, no coffee  and a few other foods and that patient was suffering from Acid Reflux and to call him back net week.
Chickenpox-like blisters on face; Chickenpox-like blisters / related to casuality of chicken pox like blisters with HZ vaccine; Redness / around the blisters; Pain around the blisters; Also experienced fever; Also experienced / malaise; This case was reported by a pharmacist via call center representative and described the occurrence of blister in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, 2 weeks after receiving Shingrix, the patient experienced blister, varicella-like rash, localized erythema, pain localized, fever and malaise. On an unknown date, the outcome of the blister, varicella-like rash, localized erythema and pain localized were unknown and the outcome of the fever and malaise were recovered/resolved.   It was unknown if the reporter considered the blister, fever and malaise to be related to Shingrix. The reporter considered the varicella-like rash, localized erythema and pain localized to be possibly related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received 2nd dose of Shingrix and experienced chickenpox like blisters on face 2 weeks post dose, which were thought to be related to herpes zoster by the reporter. The patient experienced redness and pain around the blisters 2 weeks post the dose. The patient also experienced fever and malaise the day after her second dose, both events lasted 1 day. No further information reported.
Extreme fatigue for over 72 hours. Headache for 24 hours. Muscle pain for 72 hours. Fever of 100.4 for 24 hours. Pain, redness, and swelling at injection site for over 72 hours. Fatigue and injection site pain still not gone.
Tdap, BOOSTERIX administered approximately 1600 3/9/10. PPD also placed at this time. Patient did well during vaccine administration and felt fine when leaving the exam room Patient was standing in line to make an appt. in our  lobby and fainted. When RN arrived shortly after, client was alert. Rested and rehydrated in exam room. No visible or palpable bumps noted. Client sent home.
Swelling lymph nodes, ear clogged, nauseous, elevated heart rate, headaches, began to turn bright red in the face area.
11/15/2021 Vaccination. 11/27/2021 I worked at my job. I came home and I was sitting on couch, the crown of head got super itchy and red. My whole entire body became covered in these welts; over 5 minutes total. 11/28/2021 I had horrible fatigue, stamina. I couldn't walk 50 feet. This is not normal for me as I usually have a lot of energy. Over the last few months I have had appts with PCM x2, NP, dermatologist and rheumatologist. The steroids did NOT help me out in any way. The only thing that has helped is cold compresses and not moving. I had to take a month off of my second job because I felt that horrible and couldn't be around people. The welts were itchy, 'felt on fire', 'burning'. These flare-ups come out when I am stressed and / or tired. Prescribed steroids and cream; did not help. 01/12/2021 When I got my first vaccine, my arm after a day got a big welt the size of a nerf football and went away after a week. I also had afternoon fatigue. 02/08/2021 After my second shot, I had the welt but it was the size of a lemon and a lump in my neck. That went away in a week.
Pain in arm; Pain in bones; Chills; Continue pain in male testicles; Pain in feet; Hard on speaking; Hard on focusing; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0177) via an unspecified route of administration in the right arm on 14May2021 at 14:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Patient had no allergy to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ep6955) via an unspecified route of administration in the right arm on 23Apr2021 at 14:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021 at 16:00 the patient experienced pain in arm, bone pain, chills, continue pain in testicles, hard on speaking and focusing and pain in feet. It was unknown whether therapeutic measures were taken for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event pain in arm, bone pain, chills, continue pain in testicles, hard on speaking and focusing and pain in feet was resolved with sequelae.   No follow-up attempts are needed. No further information is expected.
rash at the injection site; This case was reported by a consumer via interactive digital media and described the occurrence of injection site rash in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site rash. On an unknown date, the outcome of the injection site rash was unknown.   It was unknown if the reporter considered the injection site rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The reporter enquired whether it was common to have a rash at the injection site after a Shingrix vaccination.
Nerve block; Constant pain in back/Back pain (with radiation); Swelling shoot down left leg; Foot went numb; FACILITATED COLLECT This is a solicited report received from contactable reporter(s) (Consumer or other non HCP) for a sponsored program. The reporter is the patient. Other Case identifier(s): 22K-163-4267029-00 (AbbVie).  A 55 year-old female patient received bnt162b2 (BNT162B2), intramuscular (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation; adalimumab (HUMIRA), subcutaneous (Batch/Lot number: unknown) at citrate free for rheumatoid arthritis. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NERVE BLOCK (medically significant), outcome "unknown", described as "Nerve block"; BACK PAIN (medically significant), outcome "not recovered", described as "Constant pain in back/Back pain (with radiation)"; PERIPHERAL SWELLING (medically significant), outcome "recovering", described as "Swelling shoot down left leg"; HYPOAESTHESIA (medically significant), outcome "recovering", described as "Foot went numb". The action taken for adalimumab was unknown. Patient got a steroid shot nerve blocker in conjunction with HUMIRA injection. After that, she experienced Constant pain in back and swelling shooting down left leg and foot went numb. She reported improvement and thought it was triggered by the Covid shot. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  The reporter's causality with bnt162b2 for the event(s) Nerve block, Back pain, swelling, Numbness in feet was possible. The reporter's causality with adalimumab for the event(s) Nerve block was Reasonable possibility, Back pain, swelling, Numbness in feet was not reported. The causality as per Mfr. with adalimumab for the event(s) Nerve block, Back pain, swelling, Numbness in feet was No reasonable possibility.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the current available limited information in the case provided, the causal association between the events, Nerve block, Back pain, Peripheral swelling, Hypoesthesia and the use of suspect product BNT162B2 cannot be fully excluded. However, as the patient got a steroid shot nerve blocker in conjunction with HUMIRA injection, the reported events can be due to that also.   The case will be reassessed once further information is available   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.